| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |